| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.5 |